KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Current Taxes: 2009-2012

Historic Current Taxes for Bausch Health Companies (BHC) over the last 4 years, with Dec 2012 value amounting to $19.9 million.

  • Bausch Health Companies' Current Taxes rose 92.65% to $19.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was $19.9 million, marking a year-over-year increase of 92.65%. This contributed to the annual value of $19.9 million for FY2012, which is 92.65% up from last year.
  • Per Bausch Health Companies' latest filing, its Current Taxes stood at $19.9 million for Q4 2012, which was up 95.04% from $10.2 million recorded in Q3 2012.
  • Bausch Health Companies' Current Taxes' 5-year high stood at $67.6 million during Q2 2011, with a 5-year trough of $1.0 million in Q1 2009.
  • Its 3-year average for Current Taxes is $23.7 million, with a median of $13.3 million in 2010.
  • Per our database at Business Quant, Bausch Health Companies' Current Taxes spiked by 6,454.46% in 2010 and then tumbled by 86.74% in 2011.
  • Bausch Health Companies' Current Taxes (Quarterly) stood at $6.8 million in 2009, then surged by 33.70% to $9.2 million in 2010, then climbed by 12.91% to $10.3 million in 2011, then soared by 92.65% to $19.9 million in 2012.
  • Its Current Taxes was $19.9 million in Q4 2012, compared to $10.2 million in Q3 2012 and $15.5 million in Q2 2012.